News and features
Read the latest news and features about our world-leading research, discoveries, fundraising and philanthropy. If you want to keep updated on our news, you can follow us on social media or sign up for our Search newsletter.
If you’re a journalist and want to find out more, you can contact our media relations team.
Scan tunes out interference to detect cancer metabolism
A new type of scan uses a clever ‘noise cancelling’ technique to map cancer metabolism inside brain tumours, a new study shows.
Paul Workman visits Boston with London Mayor Boris Johnson
Professor Paul Workman, Chief Executive of The Institute of Cancer Research, London, visited the prestigious university town of Boston this week with Mayor of London Boris Johnson to promote the capital as a world-leading centre for life sciences.
Statement on today’s rejection of abiraterone before chemotherapy by the Scottish Medicines Consortium
The ICR's CEO Professor Paul Workman reacts to the news that the Scottish Medicines Consortium has rejected the use of abiraterone before chemotherapy.
ICR and The Royal Marsden to star in BBC Panorama documentary
An episode of Panorama focused entirely on the pioneering work of The Institute of Cancer Research, London, and The Royal Marsden NHS Foundation Trust is to air on BBC One next week.
Two major studies strengthen case for prostate cancer drug before chemotherapy
Pioneering prostate cancer drug abiraterone significantly extends the lives of men with advanced prostate cancer if given before chemotherapy, the results of a major phase III clinical trial have shown.
Major study links two new genetic variants to breast cancer
A worldwide study of the DNA of 100,000 women has discovered two new genetic variants associated with an increased risk of breast cancer. The genetic variants are specifically linked to the most common form of breast cancer, oestrogen receptor positive, and provide important insights into how the disease develops.
Simple tweak to MRI could sharpen images of cancers
A simple change in the processing of data from scans of cancer patients could sharpen images taken of tumours, a new study reveals.
Universities must support networking for women in science, says Professor Paul Workman
Universities must offer women more networking opportunities and training in leading large teams to help close the gender gap at the top of science – according to the head of the UK’s leading research centre. Professor Paul Workman, Chief Executive of The Institute of Cancer Research, London, urged more support for female scientists to lead ‘team science’ initiatives in a roundtable discussion at the Academy of Medical Sciences today (Monday).
Scientists find previously unknown survival signals that can keep cancer cells alive
Scientists have discovered that a key cancer protein can promote the survival of cancer cells – even when targeted by drugs designed to block its main function.
‘Bad’ genetic changes outweigh ‘good’ for blood cancer patients
Patients with myeloma whose cancer cells carry genetic changes associated with both good and bad prognosis have outcomes similar to those with bad risk changes alone, a new ICR study reports.
Using sound waves to zap away cancer
Ultrasound can be used to supply focused energy in the form of heat in a technique called high-intensity focused ultrasound. The energy from this technique can be focused and used to selectively target tumour tissue.
Cancer drugs should be licensed on smaller trials to cut prices
Earlier licensing could speed progress and reduce drug costs, global experts say.
